Citigroup Inc Accelerate Diagnostics, Inc Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.54 - $1.41 $981 - $2,563	-1,818 Reduced 78.7%	492 $0
Q1 2022 May 12, 2022	SELL	$1.4 - $5.15 $9,105 - $33,495	-6,504 Reduced 73.79%	2,310 $3,000
Q4 2021 Feb 10, 2022	BUY	$4.27 - $6.97 $18,941 - $30,918	4,436 Added 101.32%	8,814 $46,000
Q3 2021 Nov 10, 2021	BUY	$5.31 - $8.25 $23,247 - $36,118	4,378 New	4,378 $26,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $113M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.